Your browser doesn't support javascript.
loading
Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy.
Bishop, Andrew J; Ensor, Joe; Moulder, Stacy L; Shaitelman, Simona F; Edson, Mark A; Whitman, Gary J; Bishnoi, Sandra; Hoffman, Karen E; Stauder, Michael C; Valero, Vicente; Buchholz, Thomas A; Ueno, Naoto T; Babiera, Gildy; Woodward, Wendy A.
Affiliation
  • Bishop AJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ensor J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Moulder SL; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shaitelman SF; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Edson MA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Whitman GJ; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bishnoi S; Department of Electrical and Computer Engineering, Rice University, Houston, Texas.
  • Hoffman KE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Stauder MC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Valero V; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Buchholz TA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ueno NT; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Babiera G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Woodward WA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer ; 121(24): 4324-32, 2015 Dec 15.
Article in En | MEDLINE | ID: mdl-26348887
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Breast Neoplasms / Carcinoma, Lobular / Carcinoma, Ductal, Breast / Antineoplastic Agents, Hormonal / Trastuzumab / Liver Neoplasms / Lung Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Cancer Year: 2015 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Breast Neoplasms / Carcinoma, Lobular / Carcinoma, Ductal, Breast / Antineoplastic Agents, Hormonal / Trastuzumab / Liver Neoplasms / Lung Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Cancer Year: 2015 Type: Article